为什么没有临床批准的药物针对无序蛋白质?
Thomas Löhr1, Gogulan Karunanithy1, Gabriella T Heller2
1Bind Research, Apex, 1 Tribeca Walk, London, NW1 0QE, UK.
Current opinion in structural biology
|March 3, 2026
概括
内在无序蛋白 (IDP) 在健康和疾病中至关重要,但具有挑战性的药物标. 克服了解其独特的约束性和数据限制的障碍,可以为新的治疗策略解锁IDP.
科学领域:
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
- 结构生物学 结构生物学
背景情况:
- 内在无序的蛋白质 (IDP) 和区域 (IDR) 在生物调节和疾病中起着至关重要的作用.
- 与折叠蛋白相比,它们的动态,整体性质为药物开发带来了独特的挑战.
- 由于这些复杂性,目前的药物发现工作在很大程度上未充分利用了内部流离失所者.
研究的目的:
- 识别和分析阻碍国内流离失所者的治疗利用的主要障碍.
- 突出了针对境内流离失所者的药物设计新方法的需要.
- 强调需要改善IDP研究的数据资源和方法.
主要方法:
- 分析现有的生物数据库,包括生物磁共振数据库 (BMRB) 和BindingDB.
- 综述了国内流离失所者特有的非传统约束机制.
- 评估研究无序系统中的实验和计算局限性.
主要成果:
- 在当前的约束性和结构性数据库中,IDP和IDR的代表性明显不足.
- 经典的药物设计原则往往不足以针对IDP的短暂和多价值相互作用.
- 实验和计算工具中存在显著的差距,用于表征IDP行为.
结论:
- 解决已识别的障碍对于推进IDP向药物发现至关重要.
- 开发新的约束性范式和量身定制的方法是必不可少的.
- 建立社区驱动的,标准化的数据集将加速利用国内流离失所者作为治疗前沿.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73


